BDRX (Biodexa Pharmaceuticals) Inventory Turnover: 0.00 (As of Dec. 2025)

What is Biodexa Pharmaceuticals Inventory Turnover?

Biodexa Pharmaceuticals BDRX -2.00% 45 Inventory Turnover is 0.00 as of Dec. 2025. GuruFocus rates BDRX with a GF Score™ of 45/100.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Biodexa Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2025 was $3.07 Mil. Biodexa Pharmaceuticals's Average Total Inventories for the quarter that ended in Dec. 2025 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Biodexa Pharmaceuticals's Days Inventory for the six months ended in Dec. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biodexa Pharmaceuticals (NAS:BDRX) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biodexa Pharmaceuticals's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	0	/	3.074	*	365 / 2
	=	0.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biodexa Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	0	/	0
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Biodexa Pharmaceuticals Inventory Turnover Related Terms

Biodexa Pharmaceuticals Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Biodexa Pharmaceuticals's Inventory Turnover can be seen below:

Biodexa Pharmaceuticals Inventory Turnover Chart

Biodexa Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

0.00

Biodexa Pharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

45GF Score

Biodexa Pharmaceuticals PLC BDRX

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Biodexa Pharmaceuticals Inventory Turnover Calculation

Biodexa Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	5.303	/ (	(0	+	0)	/	1 )
=	5.303	/	0
=	N/A

Biodexa Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	3.074	/ (	(0	+	0)	/	1 )
=	3.074	/	0
=	N/A

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.00 mean?

Biodexa Pharmaceuticals (BDRX) has a Inventory Turnover of 0.00 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Biodexa Pharmaceuticals and its competitors.

Is Biodexa Pharmaceuticals' Inventory Turnover too high?

Biodexa Pharmaceuticals' current Inventory Turnover is 0.00. Overall, Biodexa Pharmaceuticals has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.

How does Biodexa Pharmaceuticals' Inventory Turnover compare to ADTX and AAGH?

Biodexa Pharmaceuticals' Inventory Turnover of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Biodexa Pharmaceuticals and its competitors. Biodexa Pharmaceuticals's current Inventory Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Biodexa Pharmaceuticals stock overvalued right now?

Biodexa Pharmaceuticals (BDRX) has a current Inventory Turnover of 0.00. The current Inventory Turnover is 0.00. Biodexa Pharmaceuticals' overall GF Score™ is 45/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Biodexa Pharmaceuticals (BDRX), the current Inventory Turnover is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biodexa Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies ADTX AAGH PKTX VBIO BBLG BPTH VRAX HEPA AXIM OGEN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ

Website https://www.biodexapharma.com

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

45GF Score

Get the complete analysis for BDRX

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94

Price

View BDRX Analysis

See Inventory Turnover data for all stocks →